Breaking News
Sort by:
Top Post
Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms
Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand portfolio […]
Largest Robotic Surgery Programme in UK to Tackle COVID Backlog
Guy’s and St Thomas‘ has taken delivery of a new surgical robot to help speed […]
AWS Announces AWS Healthcare Accelerator for Startups in the Public Sector
The healthcare industry is currently experiencing seismic shifts with much of the focus being placed […]
COVID-19 Welcomes a New Era in Vaccinology. mRNA Based Vaccines to Reach US$127.3 Billion by the Year 2027
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research […]
Ixaka and SomaLogic Enter Research Collaboration to Develop Bispecific Agents for Oncology
Ixaka Ltd and SomaLogic today announce a research collaboration to support the development of aptamer-based […]
Q'Apel Medical raises $22 Million to grow innovative Neurovascular access platform & Scott Huennekens joins Board of Directors
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device […]
COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials
The primary analysis of the Phase III clinical trials from the UK, Brazil and South […]
Zocdoc raises $150 million
New York-based digital healthcare marketplace Zocdoc announced $150 million in growth financing from Francisco Partners, a […]
FDA approves new treatment for adults with relapsed or refractory large-b-cell lymphoma
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy […]
Honeywell expands life sciences and software capabilities through acquisition of Sparta Systems
Honeywell today announced it has agreed to acquire privately held Sparta Systems for $1.3 billion in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more